Clinical Trial Update: Olanzapine Plus Metoclopramide for the Prevention of Opioid-Induced Nausea and Vomiting [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating olanzapine plus metoclopramide to prevent opioid-induced nausea and vomiting is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nausea
• Vomiting

Drugs mentioned

• Metoclopramide (metoclopramide)
• olanzapine (olanzapine)

Snippet

Sponsor: Affiliated Hospital of Qinghai University | Conditions: Nausea, Vomiting | Phase 3 | Status: RECRUITING